1. HBW Insight
  2. >>Archive

In Brief: ICMAD On OTC Monograph System; NSF Natural Standard; More

The Independent Cosmetic Manufacturers and Distributors recognizes the need for improvement but urged FDA to maintain ingredient approval under its OTC drug monograph system at the agency’s March 26 hearing; NSF provides an updated timeline for its natural personal-care standard; more news in brief.

Representing the Independent Cosmetic Manufacturers and Distributors, board member Craig Weiss, who is also president of the Fairfield, N.J.-based Consumer Product Testing Company, testified during FDA’s March 25 hearing on the OTC drug monograph system. According to a March 26 release from the trade association, Weiss emphasized the importance of finalizing unfinished monographs, urging FDA to issue guidance on safety and efficacy data needed to facilitate monograph ingredient approval and “to maintain approval of new ingredients by therapeutic class rather than adopting the review required for NDAs.” Specifically, he asked the agency to “revisit” pending time-and-extent applications for sunscreen active ingredients and establish procedures to expedite their review. Weiss echoed concerns raised by the Personal Care Products Council, which also offered comments at the hearing Also see "Transparency, Communication Needed In OTC Monograph System – PCPC" - HBW Insight, 26 March, 2014..

NSF International, whose work includes developing standards for consumer goods to minimize adverse health effects and protect the environment, projects...

More from Archive

FTC Consumer Privacy Policy Driven By ‘Straw Man’ Arguments – Commissioner Holyoak

 
• By Eileen Francis

The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.

FTC’s New Commissioner ‘Dismayed’ By Agency Overreach

 
• By Eileen Francis

FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements. 

Beauty Brands Not On TikTok Shop ‘Really Missing Out’ – KO-Pack

 
• By Eileen Francis

At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

More from HBW Insight

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Over The Counter: Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette

 
• By David Ridley

HBW Insight speaks to Kerry Group's RDA director for digestive health, Mathieu Millette, about the opportunity represented by the global trend for GLP-1 agonists for consumer health.

Consumers More Often Choosing Private Label First

 
• By Malcolm Spicer

First Insight report from survey conducted in April with 1,267 US consumers notes that the Private Label Manufacturers Association recorded private label sales increasing by nearly 4% in 2024 to a record $271bn.